查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138313

全球细胞分离市场-2022-2029

Global Cell Isolation Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球细胞分离市场的增长受到某些因素的推动，例如人口老龄化导致慢性病患病率上升、细胞分离技术进步、对生物製药的需求增加以及干细胞研究的增加。这些是推动市场增长的主要因素之一。

预计慢性病的增加将在预测期内推动全球细胞分离市场。

根据世界卫生组织 (WHO) 的数据，癌症每年占全球死亡人数的 13%。此外，预计未来几十年癌症发病率将增加70%，全球老龄化人口更易患癌症。预计在未来几十年内将增加近一倍。按地区划分，亚洲的癌症发病率高于其他地区。就背景而言，2012 年亚洲受癌症影响的人口为 667 万，预计到 2030 年将达到 1084 万。与所有其他地区的累积受影响人口相比，亚洲的癌症发病率很高。就增长率而言，该地区的癌症发病率也在以 2.7% 的显着复合年增长率增长。欧洲的癌症发病率第二高，其次是北美。在癌症发病率增加方面，预计欧洲在预测期内将经历最慢的增长。在癌症发病率增长方面，中东和北非和南美被认为是前两个地区，2012 年至 2030 年的复合年增长率分别为 3.1% 和 2.9%。因此，全球癌症发病率上升正在推动细胞分离市场的增长。

严格的法规、细胞分离设备的高成本以及与胚胎干细胞研究相关的伦理问题阻碍了细胞分离市场的增长。

然而，细胞分离市场受到多种因素的阻碍，例如严格的监管、细胞分离仪器的高成本以及与胚胎干细胞研究相关的伦理问题。细胞生物学研究需要使用动物和人类。这些细胞还用于可能伤害动物和人类的药物的体内毒性和药代动力学研究。此外，干细胞研究将人类胚胎用于临床应用，这往往会导致胚胎破坏。监控此类活动需要严格的监管，并由世界各地的监管机构强制执行。监管机构包括中央干细胞研究伦理委员会 (ZES)、人类受精和胚胎机构 (HFEA)、人体组织机构 (HTA) 以及药品和医疗产品监管机构 (MHRA)。因此，此类伦理问题和对研究细胞使用的限制限制了细胞生物学研究。

COVID-19 影响分析

随着 COVID-19 的爆发，实验室正在加紧研发，以寻找可以及早减轻冠状病毒症状的解决方案。这些正在进行的临床试验和研究预计将增加对细胞分离产品的需求，从而推动市场增长。

行业分析

全球细胞分离市场根据波特五力分析、供应链分析、监管分析、定价分析和未满足的需求等各种行业因素对市场进行了深入分析。

全球细胞分离市场报告提供大约 40 多个市场数据表、45 多个数字和 180 页内容。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按细胞类型划分的市场细分
  • 按细胞来源划分的市场细分
  • 按产品划分的市场细分
  • 按技术划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 慢性病增加
      • 细胞分离技术的进步
    • 限制因素
      • 细胞分离的严格法规和合规性
  • 商机
  • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 未满足的需求分析
  • COVID-19 影响分析

第 6 章按细胞类型

    • 动物细胞
    • 人体细胞
      • 干细胞
      • 分化细胞

第 7 章按细胞来源

  • 骨髓
  • 脂肪组织
  • 脐带血/胚胎干细胞

第 8 章技术

  • 通过表面标记分离细胞
  • 通过离心分离细胞
  • 通过过滤分离细胞

第 9 章按产品分类

    • 消耗品
      • 试剂和试剂盒
      • 消耗品
      • 珠子
    • 设备
      • 流式细胞仪
      • 离心机
      • 磁激活细胞分离系统
      • 过滤设备

第 10 章按应用程序

  • 癌症研究
  • 干细胞研究
  • 体外诊断
  • 生物分子的分离
  • 组织再生
  • 其他

第 11 章，最终用户

  • 医院和诊断实验室
  • 实验室、研究机构
  • 生物技术和生物製药公司
  • 细胞库
  • 其他

第 12 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 13 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 14 章公司简介

  • Becton Dickinson 公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Beckman Coulter, Inc
  • GE Healthcare
  • Merck KgaA
  • Miltenyi Biotec
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories Inc
  • Terumo BCT
  • PluriSelect Life Science UG & Co. KG
  • STEMCELL Technologies Inc（LIST NOT EXHAUSTIVE）

第15章 DataM

简介目录
Product Code: DMBT2614

Market Overview

Cell Isolation Market is expected to grow at a high CAGR of 17.2% during the forecasting period (2022 - 2029).

Cell isolation (or cell separation) is a process used for sorting cells from a heterogeneous group of cells into the specific populations without contamination. This technique helps many cell-based therapies to improve the quality of the treatment. Cell isolation techniques are widely used for biomolecule isolation for the production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Market Dynamics

The global Cell Isolation market growth driven by certain factors such as rising prevalence of chronic diseases with growing geriatric population, technological advancement in cell isolation, increasing demand for biopharmaceuticals, and increasing stem cell research. are among the key factors driving the market growth.

Rising prevalence of chronic diseases, is expected to drive the global cell isolation market during the forecast period

According to the World Health Organization (WHO), cancer accounts for 13% of deaths globally every year. Moreover, a 70% increase in cancer incidences is anticipated over the next couple of decades and the global geriatric population, as they are more prone to cancer, is anticipated to nearly double from 12% to 22%, from 2015 to 2022. By region, cancer incidence is highest in Asia compared to other regions. Contextually, the incidence population of cancers in Asia was 6.67 million in 2012 and is anticipated to reach 10.84 by 2030. The cancer incidence in Asia is higher compared to the cumulative incidence population of all other regions. In terms of growth rate too, the incidence rate of cancers is growing at a notable CAGR of 2.7% in this region. Europe has the second-highest cancer incidence, followed by North America. In terms of the increase in cancer incidence, Europe is anticipated to have the slowest growth in the forecast period. In terms of growth of cancer incidence, Middle and North Africa and South America are considered to the top two regions with CAGR of 3.1% and 2.9%, from 2012 to 2030, respectively. Hence, with the rising prevalence of cancer globally is driving the growth of the cell isolation market.

Stringent regulations, high cost of cell isolation instruments, and ethical issues related to embryonic stem cell research hampering the growth of the cell isolation market

However, the cell isolation market is hampered by several factors such as stringent regulations, high cost of cell isolation instruments, and ethical issues related to embryonic stem cell research. Cell biology research necessitates the use of animals and humans. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs, which may harm animals and humans. Also, stem cell research studies use human embryos for clinical applications that often lead to the destruction of embryos. Monitoring of such activities requires stringent regulations which are implemented by regulatory bodies globally. Some of the regulating authorities include Central Ethics Committee for Stem Cell Research (ZES), Human Fertilization and Embryology Authority (HFEA), Human Tissue Authority (HTA), Medicines and Healthcare Products Regulatory Agency (MHRA) and, among others. Hence, with the presence of such ethical concerns and restrictions on the use of cells for research is limiting cell biology research.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, research labs have increased their research and development to find solutions which can minimize the symptoms of coronavirus at early stages. These ongoing clinical trials and research is expected to increase the demand for cell isolation products, and hence driving the market growth.

Industry Analysis

The global cell isolation market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, unmet needs.

Segment Analysis

The consumables segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The consumables segment accounted for the largest market share in 2019, due to rising investments by major companies to develop technologically advanced products as well as the repetitive use of consumables. Consumables are further classified into reagents & kits, disposables, and beads. On the other hand, the instruments segment is anticipated to grow at the fastest growth rate over the forecast period, owing to advancements in products such as flow cytometers, centrifuges, magnetic-activated cell separator systems, and filtration systems. The innovations in instruments provide efficient cell separation in diagnostics, research, and other applications.

Geographical Analysis

North America region holds the largest market share of the global cell isolation market

North America region is dominating the global cell isolation market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure for life science research, the large presence of major players focusing on the development of novel treatments, and rising prevalence of cancer in this region. For instance, according to the estimates of the GLOBOCAN in 2020, there were an estimated 2,281,658 new cancer cases diagnosed and 612,390 deaths due to cancer in the United States. The Canadian Cancer Society (CCS) estimated that in 2020, approximately 29,800 Canadians would be diagnosed with lung cancer. Represents 13% of all new cancer cases. About 21,200 Canadians are expected to die from lung cancer. Means 25% of all cancer deaths in 2020. In addition, increasing government support for cancer and stem cell research and the expansion of biotechnology and biopharmaceutical industries globally are contributing to the growth of the market. In April 2018, STEMCELL Technologies announced a US$ 45 million joint agreement between the governments of Canada and British Columbia to help the company build an advanced manufacturing facility.

Competitive Landscape

The global cell isolation market is fragmented with major players dominating the market. Some of the major players contributing to the growth of the cell isolation market are Becton Dickinson and Company, Beckman Coulter, Inc., GE Healthcare, Merck KgaA, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., among others. The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Cell Isolation market globally. For instance,

In November 2019, MicroMedicine, Inc., a life sciences technology company, launched its patented one-of-a-kind white blood cell isolation technology, the Sorterra Cell Isolation System. This new automated technology gently and reliably isolates white blood cells from human peripheral blood using microfluidic channels without the use of centrifugation or labelling. Sorterra is intended for use in research and development and clinical research labs. Global Cell Isolation Market - Key Companies to Watch

Bio-Rad Laboratories

Overview: Bio-Rad Laboratories, Inc. is an American company that continued to produce innovative and useful products in the healthcare industry that assist life science researchers in accelerating the discovery process, and medical diagnostic labs obtain faster better results.

Product Portfolio: Bio-Plex Multiplex System- The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples.

The global cell isolation market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Cell Type
  • 3.2. Market snippet by Cell Source
  • 3.3. Market snippet by Product
  • 3.4. Market snippet by Technique
  • 3.5. Market snippet by Application
  • 3.6. Market Snippet by End-User
  • 3.7. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
      • 4.1.1.2. Technological Advancement in Cell Isolation
      • 4.1.1.3. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Strict Regulations and Compliances for Cell Separation
      • 4.1.2.2. XX
  • 4.2. Opportunity
  • 4.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. COVID-19 Impact Analysis

6. By Cell Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type Segment
  • 6.3. Market Attractiveness Index, By Cell Type Segment
    • 6.3.1. Animal Cells*
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 6.3.2. Human Cells
      • 6.3.2.1. Stem Cells
      • 6.3.2.2. Differentiated Cells

7. By Cell Source

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source Shape
  • 7.3. Market Attractiveness Index, By Cell Source Segment
    • 7.3.1. Bone Marrow*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Adipose Tissue
    • 7.3.3. Cord Blood/Embryonic Stem Cells

8. By Technique

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique Segment
  • 8.3. Market Attractiveness Index, By Technique Segment
    • 8.3.1. Surface Marker-Based Cell Isolation*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Centrifugation-Based Cell Isolation
    • 8.3.3. Filtration-Based Cell Isolation

9. By Product

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 9.3. Market Attractiveness Index, By Product Segment
    • 9.3.1. Consumables*
      • 9.3.1.1.
      • 9.3.1.1.1. Introduction
      • 9.3.1.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      • 9.3.1.2. Reagents & kits
      • 9.3.1.3. Disposables
      • 9.3.1.4. Beads
    • 9.3.2. Instruments
      • 9.3.2.1. Flow cytometers
      • 9.3.2.2. Centrifuges
      • 9.3.2.3. Magnetic-activated cell separator systems
      • 9.3.2.4. Filtration systems

10. By Application

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 10.3. Market Attractiveness Index, By Application Segment
    • 10.3.1. Cancer Research*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 10.3.2. Stem Cell Research
    • 10.3.3. In Vitro Diagnostics
    • 10.3.4. Biomolecule Isolation
    • 10.3.5. Tissue Regeneration
    • 10.3.6. Others

11. By End-User

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
  • 11.3. Market Attractiveness Index, By End-User Segment
    • 11.3.1. Hospitals and Diagnostic Laboratories*
      • 11.3.1.1. Introduction
      • 11.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 11.3.2. Research Laboratories and Institutes
    • 11.3.3. Biotechnology and Biopharmaceutical Companies
    • 11.3.4. Cell Banks
    • 11.3.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.9.1. The U.S.
      • 12.2.9.2. Canada
      • 12.2.9.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.9.1. Germany
      • 12.3.9.2. The U.K.
      • 12.3.9.3. France
      • 12.3.9.4. Italy
      • 12.3.9.5. Spain
      • 12.3.9.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.9.1. Brazil
      • 12.4.9.2. Argentina
      • 12.4.9.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.9.1. China
      • 12.5.9.2. India
      • 12.5.9.3. Japan
      • 12.5.9.4. Australia
      • 12.5.9.5. Rest of Asia Pacific
  • 12.6. The Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Becton Dickinson and Company*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Beckman Coulter, Inc
  • 14.3. GE Healthcare
  • 14.4. Merck KgaA
  • 14.5. Miltenyi Biotec
  • 14.6. Thermo Fisher Scientific
  • 14.7. Bio-Rad Laboratories Inc
  • 14.8. Terumo BCT
  • 14.9. PluriSelect Life Science UG & Co. KG
  • 14.10. STEMCELL Technologies Inc (LIST NOT EXHAUSTIVE)

15. DataM Intelligence

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us